Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

42.40 +0.80 (+1.91%)
Streaming Delayed Price Updated: 10:22 AM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Inari Medical Inc

< Previous 1 2 3 4 Next >
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
What 8 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Inari Medical
Via Benzinga
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024
NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Market Cap Game Show: Andy Cross vs. Bill Mann
Join the "Rule Breaker Investing" fun. 
Via The Motley Fool
Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
Via Benzinga
Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by over 100 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Inari Medical Q4 Earnings
Via Benzinga
Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
Why Shares of Inari Medical Are Up Thursday
The company announced second-quarter earnings. 
Via The Motley Fool
Looking Into Inari Medical's Return On Invested Capital
Via Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
Inari Medical: Q1 Earnings Insights
Via Benzinga
Why Shares of Inari Medical Rose This Week
The medical equipment maker's stock has climbed by $10 a share since the start of the month. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Top Healthcare Stocks I'd Buy Now Without Hesitation
Whether you're seeking dividends or explosive growth, the economy's most reliable sector has something for you. 
Via The Motley Fool
Inari Medical Stock Gained 21% on Thursday - Here's Why It Soared
Inari Medical Inc (NASDAQ: NARI) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the  
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90... 
Via Benzinga
Inari Medical Earnings Preview
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Find out why the investment bankers who follow these stocks think they can soar in the near term. 
Via The Motley Fool
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.